Reply to Martin and Grasemann: Is there a role for lumacaftor/ivacaftor in young children with cystic fibrosis?
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
March 2025
|
| In: |
Annals of the American Thoracic Society
Year: 2025, Jahrgang: 22, Heft: 3, Pages: 469-470 |
| ISSN: | 2325-6621 |
| DOI: | 10.1513/AnnalsATS.202411-1237LE |
| Schlagworte: | |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1513/AnnalsATS.202411-1237LE Verlag, kostenfrei, Volltext: https://www.atsjournals.org/doi/10.1513/AnnalsATS.202411-1237LE 
|
| Verfasserangaben: | Mirjam Stahl, M.D., Jobst Röhmel, M.D., Mark O. Wielpütz, M.D., Marcus A. Mall, M.D. |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1935986732 | ||
| 003 | DE-627 | ||
| 005 | 20250929103109.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250915s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1513/AnnalsATS.202411-1237LE |2 doi | |
| 035 | |a (DE-627)1935986732 | ||
| 035 | |a (DE-599)KXP1935986732 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Stahl, Mirjam |e VerfasserIn |0 (DE-588)1050007778 |0 (DE-627)783125836 |0 (DE-576)404265367 |4 aut | |
| 245 | 1 | 0 | |a Reply to Martin and Grasemann: Is there a role for lumacaftor/ivacaftor in young children with cystic fibrosis? |c Mirjam Stahl, M.D., Jobst Röhmel, M.D., Mark O. Wielpütz, M.D., Marcus A. Mall, M.D. |
| 264 | 1 | |c March 2025 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.09.2025 | ||
| 655 | 7 | |a Brief |0 (DE-588)4008240-4 |0 (DE-627)104675365 |0 (DE-576)208875212 |2 gnd-content | |
| 700 | 1 | |a Röhmel, Jobst Fridolin |e VerfasserIn |0 (DE-588)1072431009 |0 (DE-627)827486219 |0 (DE-576)433856475 |4 aut | |
| 700 | 1 | |a Wielpütz, Mark Oliver |d 1982- |e VerfasserIn |0 (DE-588)139999752 |0 (DE-627)614754682 |0 (DE-576)314127046 |4 aut | |
| 700 | 1 | |a Mall, Marcus A. |d 1975- |e VerfasserIn |0 (DE-588)115507795 |0 (DE-627)691370532 |0 (DE-576)28992152X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a American Thoracic Society |t Annals of the American Thoracic Society |d New York, NY : American Thoracic Society, 2013 |g 22(2025), 3 vom: März, Seite 469-470 |h Online-Ressource |w (DE-627)736121897 |w (DE-600)2702474-X |w (DE-576)378731726 |x 2325-6621 |7 nnas |
| 773 | 1 | 8 | |g volume:22 |g year:2025 |g number:3 |g month:03 |g pages:469-470 |g extent:2 |a Reply to Martin and Grasemann: Is there a role for lumacaftor/ivacaftor in young children with cystic fibrosis? |
| 787 | 0 | 8 | |i Ergänzung zu |a Martin, Isaac |t Is there a role for lumacaftor/ivacaftor in young children with cystic fibrosis? |d 2025 |w (DE-627)1937165191 |
| 856 | 4 | 0 | |u https://doi.org/10.1513/AnnalsATS.202411-1237LE |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.atsjournals.org/doi/10.1513/AnnalsATS.202411-1237LE |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250915 | ||
| 993 | |a Editorial | ||
| 994 | |a 2025 | ||
| 998 | |g 139999752 |a Wielpütz, Mark Oliver |m 139999752:Wielpütz, Mark Oliver |d 50000 |e 50000PW139999752 |k 0/50000/ |p 3 | ||
| 998 | |g 1050007778 |a Stahl, Mirjam |m 1050007778:Stahl, Mirjam |d 50000 |e 50000PS1050007778 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1935986732 |e 4772450416 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"role":"aut","given":"Mirjam","display":"Stahl, Mirjam","family":"Stahl"},{"family":"Röhmel","display":"Röhmel, Jobst Fridolin","given":"Jobst Fridolin","role":"aut"},{"family":"Wielpütz","display":"Wielpütz, Mark Oliver","given":"Mark Oliver","role":"aut"},{"family":"Mall","display":"Mall, Marcus A.","role":"aut","given":"Marcus A."}],"physDesc":[{"extent":"2 S."}],"name":{"displayForm":["Mirjam Stahl, M.D., Jobst Röhmel, M.D., Mark O. Wielpütz, M.D., Marcus A. Mall, M.D."]},"recId":"1935986732","relHost":[{"corporate":[{"display":"American Thoracic Society","role":"aut"}],"part":{"pages":"469-470","year":"2025","issue":"3","text":"22(2025), 3 vom: März, Seite 469-470","volume":"22","extent":"2"},"titleAlt":[{"title":"AnnalsATS"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"American Thoracic SocietyAnnals of the American Thoracic Society","note":["Gesehen 06.01.2026"],"pubHistory":["10.2013 -"],"origin":[{"dateIssuedKey":"2013","publisher":"American Thoracic Society","dateIssuedDisp":"2013-","publisherPlace":"New York, NY"}],"title":[{"title_sort":"Annals of the American Thoracic Society","title":"Annals of the American Thoracic Society"}],"id":{"eki":["736121897"],"issn":["2325-6621"],"zdb":["2702474-X"]},"recId":"736121897","physDesc":[{"extent":"Online-Ressource"}]}],"id":{"doi":["10.1513/AnnalsATS.202411-1237LE"],"eki":["1935986732"]},"title":[{"title_sort":"Reply to Martin and Grasemann: Is there a role for lumacaftor/ivacaftor in young children with cystic fibrosis?","title":"Reply to Martin and Grasemann: Is there a role for lumacaftor/ivacaftor in young children with cystic fibrosis?"}],"origin":[{"dateIssuedDisp":"March 2025","dateIssuedKey":"2025"}],"note":["Gesehen am 15.09.2025"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a STAHLMIRJAREPLYTOMAR2025 | ||